Cargando…
Overexpression of Prohibitin 2 Protein is Associated with Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia
Cytogenetically normal acute myeloid leukemia (CN-AML) accounts for 40%–50% of all AML cases. Despite advances in understanding the molecular pathophysiology of CN-AML, its clinical outcome remains unsatisfactory and unpredictable. To investigate its clinical implication in CN-AML, we measured the e...
Autores principales: | Lee, Young Eun, Lim, Ha Jin, Park, Ju Heon, Kim, Hye Ran, Kang, Min-Gu, Cho, Young Kuk, Shin, Jong Hee, Shin, Myung Geun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Laboratory Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057826/ https://www.ncbi.nlm.nih.gov/pubmed/35470276 http://dx.doi.org/10.3343/alm.2022.42.5.585 |
Ejemplares similares
-
Overexpression of ATP1B1 predicts an adverse prognosis in cytogenetically normal acute myeloid leukemia
por: Shi, Jin-long, et al.
Publicado: (2015) -
KRAS overexpression independent of RAS mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia
por: Zhou, Jing-Dong, et al.
Publicado: (2017) -
Phospholipase C Beta 2 Protein Overexpression Is a Favorable Prognostic Indicator in Newly Diagnosed Normal Karyotype Acute Myeloid Leukemia
por: Park, Mi Suk, et al.
Publicado: (2021) -
High expression of MAP7 predicts adverse prognosis in young patients with cytogenetically normal acute myeloid leukemia
por: Fu, Lin, et al.
Publicado: (2016) -
Cytogenetics’ impact on the prognosis of acute myeloid leukemia
por: Gupta, Monika, et al.
Publicado: (2019)